Magnetic sphincter augmentation (MSA) has proven to be safe and effective for appropriate candidates with gastroesophageal reflux disease (GERD).
Results | A total of 31 patients were treated with MSA and were included. The Table provides perioperative descriptive statistics for the total cohort with comparison statistics for both SI and EI groups. Median follow-up was 12 months. Average preoperative score on the G-QOL survey was 41.2 of a maximum of 75, with mean postoperative score being 8.3. This yielded a mean preoperative and postoperative difference in survey score of 32.4 or 79% improvement. Comparison of G-QOL and comparison of postoperative outcomes for the SI and EI groups are represented in the Figure. Fifteen patients (48%) were categorized in the EI group including 6 prior sleeve gastrectomies, 2 prior fundoplications, 1 prior gastric bypass, 5 with hiatal hernias larger than 3 cm and 1 with a BMI of 37. Overall complication rate (to include prolonged dysphagia and reoperation) was not significantly different between the SI group (15%) and EI group (20%) (P = .46). One patient who required reoperation for reherniation was in the EI group for a previously failed fundoplication. Gastroesophageal reflux disease improvement was equivalent between the 2 groups with 84% improvement for the SI group vs 74% for the EI group (P = .28). On G-QOL, no patients (100%) recorded that they were unsatisfied in the EI group and all but 1 patient (93%) marked that they were satisfied with their postoperative outcome in the SI group (P = .76). Discussion | Outcomes after MSA at our single tertiary referral center found MSA to be safe and effective for the treatment of GERD, with relatively low complication rates and acceptable degrees of improvement in subjective GERD symptoms and in G-QOL survey scores for all patients. Of greatest importance, results were equivalent even when using MSA for expanded indications, such as larger hiatal hernias, higher BMI, or prior foregut surgery.
There is a paucity of literature evaluating MSA for expanded indications. Onset of GERD following bariatric procedures is a challenging problem, particularly following sleeve gastrectomy.
2 When conversion to Roux-en-Y is not possible or desired, MSA is an alternative that has been found to be highly feasible and effective. 3,4 Although fundoplication has been compared with MSA, no current studies address MSA for refractory GERD after fundoplication or for patients with larger hiatal/paraesophageal hernias. 5 We found that MSA was an excellent option even among patients with these more challenging anatomic abnormalities. However, these results are limited by the retrospective nature of this analysis and the small sample size, which is significantly underpowered to identify differences in less common complications or to definitively demonstrate noninferiority. Finally, we cannot draw any conclusions about longer-term outcomes in terms of device durability and sustained control of GERD symptoms. Although further prospective studies are needed, there is exciting potential for MSA in providing surgeons a new tool in their armamentarium against refractory or de novo GERD associated with larger hiatal hernias, higher BMI, or following prior foregut surgery. 
A Model for Military-Civilian Collaboration in Academic Surgery Beyond Trauma Care
Providing comprehensive surgical training and sustaining medical readiness of military surgeons remains challenging, especially during peacetime. We summarize a militarycivilian partnership that extends beyond trauma. 
